Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1956 4
1957 6
1973 1
1984 1
1985 1
1987 2
1989 3
1990 2
1992 2
1993 2
1995 3
1996 3
1998 1
1999 3
2000 7
2001 3
2002 5
2003 6
2004 9
2005 8
2006 13
2007 14
2008 20
2009 11
2010 15
2011 24
2012 42
2013 18
2014 30
2015 51
2016 55
2017 41
2018 40
2019 24
2020 26
2021 26
2022 20
2023 23

Text availability

Article attribute

Article type

Publication date

Search Results

538 results

Results by year

Filters applied: . Clear all
Page 1
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Among authors: corradi m. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
[Laboratory animal allergy.].
Corradi M, Selis L, Pelà G, Mozzoni P, Andreoli R, Goldoni M. Corradi M, et al. G Ital Med Lav Ergon. 2019 Dec;41(4):354-358. G Ital Med Lav Ergon. 2019. PMID: 32126609 Italian.
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Singh D, Papi A, Corradi M, Pavlišová I, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Vestbo J. Singh D, et al. Among authors: corradi m. Lancet. 2016 Sep 3;388(10048):963-73. doi: 10.1016/S0140-6736(16)31354-X. Epub 2016 Sep 1. Lancet. 2016. PMID: 27598678 Clinical Trial.
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.
Vestbo J, Papi A, Corradi M, Blazhko V, Montagna I, Francisco C, Cohuet G, Vezzoli S, Scuri M, Singh D. Vestbo J, et al. Among authors: corradi m. Lancet. 2017 May 13;389(10082):1919-1929. doi: 10.1016/S0140-6736(17)30188-5. Epub 2017 Apr 3. Lancet. 2017. PMID: 28385353 Clinical Trial.
Sex-Related Differences in Long-COVID-19 Syndrome.
Pelà G, Goldoni M, Solinas E, Cavalli C, Tagliaferri S, Ranzieri S, Frizzelli A, Marchi L, Mori PA, Majori M, Aiello M, Corradi M, Chetta A. Pelà G, et al. Among authors: corradi m. J Womens Health (Larchmt). 2022 May;31(5):620-630. doi: 10.1089/jwh.2021.0411. Epub 2022 Mar 25. J Womens Health (Larchmt). 2022. PMID: 35333613
Lung cancer biomarkers in exhaled breath.
Amann A, Corradi M, Mazzone P, Mutti A. Amann A, et al. Among authors: corradi m. Expert Rev Mol Diagn. 2011 Mar;11(2):207-17. doi: 10.1586/erm.10.112. Expert Rev Mol Diagn. 2011. PMID: 21405971 Review.
[Laboratory animal; allergy; asthma].
Corradi M, Romano C, Mutti A. Corradi M, et al. Med Lav. 2011 Sep-Oct;102(5):428-44. Med Lav. 2011. PMID: 22022762 Review. Italian.
538 results